Expanding Flp-RMCE options: the potential of Recombinase Mediated Twin-Site Targeting (RMTT)

Area of Science:

• Gene therapy
• Molecular biology
• Cell line engineering

Background:

• Stable cell line development relies on predictable gene integration.
• Lentiviral vectors are effective for gene delivery but require controllable expression.
• Current methods like Cre/loxP excision have limitations.

Purpose of the Study:

• To develop a new system for precise gene expression control and termination.
• To replace the phage-derived Cre/loxP system with a yeast Flp/FRT system.
• To enable advanced gene targeting strategies for cell line development.

Main Methods:

• Utilized the yeast Flp/FRT site-specific recombination system.
• Developed lentiviral vectors with "twin-sites" (FF3 fusion).
• Implemented Recombinase-Mediated Twin Site Targeting (RMTT) for gene insertion.

Main Results:

• The Flp/FRT system allows for effective excision of expression cassettes.
• FF3 twin sites serve as identifiable and analyzable genomic anchors.
• RMTT enables targeted gene accommodation at specific loci, creating certified cell lines.

Conclusions:

• The Flp/FRT system offers enhanced flexibility and control over gene expression compared to Cre/loxP.
• RMTT, combined with FF3 twin sites, facilitates the creation of stable, compliant cell lines.
• This approach expands possibilities for lentiviral targeting and fine-tuning gene expression.